Current Clinical Trials

Would you like to know if you qualify for one of our current clinical trials? If so, then please register for one of our studies below. Your personal contact information will never be shared with anyone outside of TMA. We will remove your information from our database at any time you wish; just call us at (910) 833-1954. We look forward to speaking with you.

Current Clinical Trials at TMA

FLU Vaccine

Millions of people come down with influenza (flu) every year, and it affects people differently, but complications of flu include pneumonia, ear infections, sinus infections and worsening of chronic medical conditions such as CHF, asthma or diabetes. Scientists are working to create a more protective vaccine, and we are currently testing one here. By participating in this trial, you will be protected against the flu and help us test a new flu vaccine.

To join, you:

must be 18 years or older
must not have received your flu vaccine in the past 6 months

What to Expect:

Length of the trial is approximately 6-12 moths
Up to 4 clinical site visits
Weekly communication via e-diary
Compensation for time and travel of about $400

Fill out the volunteer form here if you’d like to be considered for the Flu Vaccine clinical trial.

FLU Vaccine

To join, you:

must be 18 years or older
must not have received your flu vaccine in the past 6 months

What to expect:

Length of the trial is approximately 6-12 months
Up to 4 clinical site visits
Weekly communication via e-diary
Compensation for time and travel of about $400

Fill out the volunteer form here if you’d like to be considered for the Flu Vaccine clinical trial.

RSV Vaccine

Respiratory syncytial virus (RSV) is a common respiratory virus that infects the lungs and breathing passages. RSV causes about 177,000 hospitalizations and 14,000 deaths in those over 65 years of age annually in the U.S. It is also the second leading cause of significant respiratory tract illnesses in adults, only behind influenza. The purpose of this clinical trial is to assess the safety of an investigational vaccine aimed at preventing RSV infection in people over 60 years of age or older.

To participate, you must be:

60 years of age and older
In good health
Primarily responsible for self-care

What to expect:

Length of the study is approximately 2 years
8 visits to the clinical site
Brief communication via telephone, email, or text messages
Compensation for time and travel is about $3000

Fill out the volunteer form here if you’d like to qualify for the RSV (Respiratory syncytial virus) Vaccine clinical trial.

FLU+RSV Vaccine

Fill out the volunteer form here if you’d like to participate in the FLU and RSV (Respiratory syncytial virus) Vaccine clinical trial.

Lung & Colorectal Cancer Screening Study

This research study is now enrolling to see if it is possible to develop
a cancer screening test based on blood samples.
The study will use blood samples collected from volunteers
who are undergoing routine lung or colon screening.

The purpose of this research study is to collect blood samples and medical information to help in the development of a blood test that can screen for many cancers from a single blood draw. This is an experimental test which is still under development, the goal of this blood test is to help doctors find cancers early, potentially at a time when tumours are still small.
Researchers will look at markers in the blood that show up when cancer is just developing. These findings from the blood, your medical history and results from your routine cancer screening will be used to develop this cancer screening blood test.

Who can take part in this trial?

Women and men aged between 49-85 years undergoing routine colonoscopy screening.
Women and men aged between 50-80 years undergoing routine lung cancer screening.
We are looking for about 75,000 participants from around the world.

Will I be paid to participate in this study?

To thank you for your time for participating in this research study, you will receive $200 after every blood draw (50 mL of blood) that you provide.
For each additional blood sample (50 mL of blood) you provide every year for the 4 years this study will last, you will receive an additional $200.
You may be reimbursed for other reasonable costs associated with blood draw visits (for example, transportation, parking) to travel from your home to the blood draw laboratory or facility.

Fill out the volunteer form here if you’d like to participate in the Lung & Colorectal Cancer Screening Study.

COVID/FLU Combo Vaccine Study

The main focus for the study is to see if the new formulation will reduce shot burden for patients by giving simultaneous protection.

This is a 6 month study with 5 in person visits and 4 safety phone calls. There will be compensation for your time and travel.

In order to participate:

Must be fully vaccinated for COVID with primary series (at least) and all doses received at least 120 days ago

Fill out the volunteer form here if you’d like to participate in the COVID/FLU Combo Vaccine Study.

Pneumococcal Vaccine

Pneumococcal Disease is an illness caused by certain germs (bacteria), called streptococcus pneumoniae. These germs can cause serious infections in the ears, nose, lungs, blood, or brain. The purpose of this clinical trial is to assess the safety of an investigational vaccine aimed at protecting adults against pneumococcal disease.

To join, you must be:

18 years and older
Pneumococcal vaccine naïve

What to expect:

Length of the study is approximately 6 months
2 visits to the clinical site
4 brief communications via telephone or e-diary
Compensation for time and travel is about $400

Fill out the volunteer form here if you’d like to qualify for a Pneumococcal Vaccine clinical trial.

Pneumococcal Vaccine

To join, you must be:

18 years and older
Pneumococcal vaccine naïve

What to expect:

Length of the study is approximately 6 months
2 visits to the clinical site
4 brief communications via telephone or e-diary
Compensation for time and travel is about $400

Fill out the volunteer form here if you’d like to qualify for a Pneumococcal Vaccine clinical trial.

Colorectal Screening

Fill out the volunteer form here if you’d like to qualify for a Colorectal Screening clinical trial.

COVID Booster Vaccine Study

We are looking for healthy participants 18+ to be a part of our COVID BOOSTER Vaccine trial. This trial is looking at a new formulation for the Covid booster at a lower dose with a longer expiration.

This is a 12 months study, 5 in-person visits and 4 phone calls throughout the duration of the study. There will be compensation for your time and travel.

Must have received 4 prior doses of Covid 19-mRNA vaccine (primary series + 2 booster shots) in order to participate.

Fill out the volunteer form here if you’d like to qualify for the COVID Booster Vaccine Study.

Obesity Study

This Phase 3 study evaluates the safety and body weight reduction with LY3437943 to treat participants who have obesity or overweight with at least one weight-related comorbid condition.

We are looking for participants 18+ who have a BMI • ≥27 kg/m2.

Fill out the volunteer form here if you’d like to qualify for the Obesity Study.

TYPE 2 Diabetes Study

Fill out the volunteer form here if you’d like to qualify for the TYPE 2 Diabetes Study.

Refer a Friend and Receive $100

We are offering a Refer-A-Friend Bonus! For every person you recommend that enrolls in a TMA study you will receive $100!*

We are currently seeking volunteers for the following studies:
Flu Vaccine, RSV Vaccine, Pneumococcal Vaccine, Smoking Cessation

To refer a friend or see if you qualify, please call 910-833-1954 or fill out a volunteer form here.

* The $100 referral payment will be made to your existing ClinCard at the time the referred patient enrolls into the trial. An enrolled patient is defined as a patient that successfully completes the screening and Day 1 visit. The referred patient’s information and study participation status will be kept confidential, and they will be made aware that someone referred them to the trial and that they may receive payment.